Connect with us
European Gaming Congress 2024

Artificial Intelligence

Biopharmaceuticals Market Revenue to Reach USD 8,56,100 Million by 2030

Published

on

Ottawa, Aug. 04, 2023 (GLOBE NEWSWIRE) — The global biopharmaceuticals market revenue accounted for USD 3,73,600 million in 2023, a study published by Towards Healthcare a sister firm of Precedence Research.

Biopharmaceuticals Are Complex Medicines Derived From Living Cells Or Organisms And Are Frequently Created Using Cutting-Edge Biotechnological Techniques.

A biopharmaceutical, also known as a “biologic,” is a medical therapeutic (or drug) derived from a biological source, such as a cell. Biotechnology is used to directly extract proteins and nucleic acids from biological sources to produce biopharmaceuticals, which are drugs used in medicine. Transgenic organisms are genetically modified plants and animals that are used in the production of biopharmaceuticals, which are pharmaceuticals made primarily from living organisms. This controversial technology is still in the trial stage.

Download a White Paper @ https://www.towardshealthcare.com/personalized-scope/5012

Influencers Fueling The Market Growth:

Advertisement

Biopharmaceuticals are in high demand

The primary factor propelling the growth of this market is the enormous demand for biopharmaceuticals brought on by the increase in chronic diseases and the aging population. Additionally, it is anticipated that the ability of biopharmaceuticals to treat untreatable conditions will speed up the market’s overall growth.

Additionally, the population’s growing awareness of the efficacy and accessibility of biopharmaceuticals as well as the expanding healthcare sector is anticipated to temper market growth during the anticipated time frame. The market is expected to grow as a result of the increased efforts being made to develop the biopharmaceutical sector.

Hurdles Faced During The Market Expansion

The risk of failure and the high cost of drug development are the main things preventing the global biopharmaceutical industry from expanding. Furthermore, the market is unable to grow internationally due to strict regulatory requirements, high development costs, and the cost of biopharmaceutical drugs. Currently, biopharmaceutical companies, health professionals, and stakeholders face numerous challenges and struggles during the development of new bio drugs and prior to the commercialization of these novel products. For example, according to pharmaceutical protocols, every bio-drug undergoes numerous steps and procedures prior to marketing, including animal and clinical studies. Indeed, this new medicine would be tested on laboratory animals during the development process; however, there may be a scarcity of animal samples or restrictions on their use because there are associations and animal rights organizations that consider the use of some animals in scientific tests or other scientific purposes to be a form of torture and unethical practice.

Advertisement

Open Door For The Biopharmaceutical Market:

Growing Investments And Research To Foster Innovation

Moreover, it is predicted that the market will benefit greatly from the increased emphasis on research and associated investments. Numerous opportunities for market expansion will also be provided by the increased government funding for the development of the biopharmaceutical industry as well as the increased investments made by market participants in the research and development of new drugs and their clinical trials.

Impact Of COVID-19 On The Biopharmaceutical Market

The development of COVID-19 has significantly strained healthcare infrastructure. The pandemic had a moderate impact on the biopharmaceuticals market. The government’s implementation of the lockdown and social isolation measures to control the COVID-19 pandemic outbreak resulted in several operations ceasing, supply chains becoming disrupted, business growth slowing down, technology events being postponed, new developments being suspended, as well as having an effect on overall production and sales, which in turn constrained the market’s growth. Researchers from all over the world are trying to come up with solutions to this mounting problem. As a result, it is anticipated that there will be a shortage of COVID-19-specific monoclonal antibodies. Itolizumab (ALZUMAb), an anti-CD6 IgG1 monoclonal antibody from Biocon Ltd in India, was approved by the Drugs Controller General of India (DCGI) in July 2020 for the immediate treatment of cytokine release syndrome in patients infected with COVID-19-acute respiratory distress syndrome.

Advertisement

Personalized your customization here: https://www.towardshealthcare.com/customization/5012

Market Scope and Categorization

During the current pandemic, almost all biopharmaceutical companies in the area have been working to develop efficient COVID-19 treatments, which is anticipated to accelerate the market’s growth over the pandemic.

The demand for efficient medications will increase due to an increase in research and development spending as well as an increase in the incidence of cancer over the course of the next five years. According to GLOBOCAN 2020, there will be 2,281,658 new cases of cancer in the United States in 2020, along with 612,390 fatalities. As a result of the existence of these growth-determining factors, the market is moving forward and is anticipated to experience significant growth during the anticipated period. According to estimates, the market for biopharmaceuticals will grow quickly, offering numerous income opportunities.

The largest market share is anticipated to belong to monoclonal antibodies.

Advertisement

The successful application of monoclonal antibodies and antibody derivatives in therapeutics is the main factor influencing the segment’s quick expansion. Monoclonal antibodies have been used as treatments for cardiovascular disease, cancer, rheumatoid arthritis, and multiple sclerosis.

Healthcare systems are being heavily burdened by the COVID-19 outbreak. Researchers from all over the world are constantly working to address this growing burden. As a result, the market for monoclonal antibodies that target COVID-19 is anticipated to grow significantly. For instance, the Drug Controller General of India (DCGI) authorized the use of Itolizumab (ALZUMAb), an anti-CD6 IgG1 monoclonal antibody, in July 2020 for the urgent treatment of cytokine release syndrome in acute respiratory distress patients.

Additionally, the demand for effective options for disease prevention, treatment, and complete eradication is growing, which is contributing to an increase in pharma R&D spending. Many pharmaceutical firms are concentrating on creating more potent medicines to treat fatal illnesses and enable patients to lead healthier lives with fewer disabilities. Global healthcare spending is essentially driving up R&D activities, which is boosting the number of bio-based pharmaceutical products on the market.

A new phase of biological therapies for neoplastic disorders, infectious diseases, and multiple sclerosis has also been made possible by cytokines and interferons (IFNs). These agents mediate their biological effects indirectly, through several immunological and other cells, or accessory proteins.

Depending on the end-use sector, the biopharmaceuticals market can be further divided into the following categories: health and care, biopharma companies, diagnostic labs, clinical research institutes, clinical research organizations (CROs), and others. In 2021, the segment representing biopharma companies held the largest market share. This expansion is mainly due to the significant advancements in modern medicine and their use in treating complex diseases. This segment’s growth is currently being further fueled by the recent improvements in molecular medicines and R&D made by numerous top industry players and governmental organizations.

Advertisement

Additionally, the Clinical Research Organizations segment is anticipated to expand at the fastest CAGR of 9.1% from 2022 to 2027 as a result of an increase in research into the creation of new molecular drugs using molecular biology.

In terms of revenue, the oncology segment will dominate the global biopharmaceutical market in 2020. This is simply due to the increased use of biopharmaceuticals in the treatment of cancers such as lung cancer, breast cancer, colorectal cancer, and prostate cancer. Global cancer cases are increasing at an alarming rate. According to the International Agency for Research on Cancer, the global cancer burden is expected to reach 28.4 million by 2040, up 47% from 2020.

Cardiovascular disease, on the other hand, is expected to be the most opportunistic segment during the forecast period. According to World Health Organization, approximately 17.9 million people die each year as a result of cardiovascular diseases, accounting for approximately 32% of all global deaths. As a result, the increased prevalence of CVDs around the world, as well as rising investments by biopharmaceutical manufacturers in developing innovative CVD drugs, are expected to drive market growth during the forecast period.

Related Reports:

  • Hospital Services Market: the global hospital services market revenue was valued at USD 9,576.6 billion in 2020 and is estimated to reach around USD 16,449.0 billion by 2027, growing at a CAGR of 7.87% from 2020 to 2027.
  • AI In Life Sciences Market: The global artificial intelligence in life sciences market size was estimated at USD 1,560 million in 2022 and it is expected to reach around US$ 6,700 million by 2030, growing at a CAGR of 20% from 2022 to 2030.
  • AI in Drug Discovery Market: The global artificial intelligence in drug discovery market size reached USD 1,495.28 million in 2022 and it is expected to reach around US$ 11,914 million by 2030, growing at a CAGR of 29.62% from 2022 to 2030.

North America is projected to be the market king.

The primary drivers of the biopharmaceuticals market in North America are the rising burden of chronic diseases and rising investments in research and development activities in the United States. The world’s center of life sciences innovation has long been acknowledged to be in the United States. It participates in international capital investments in biopharmaceutical startups.

Advertisement

The North American biopharmaceutical market is anticipated to grow as a result of the increase in COVID-19-related clinical trials. Nearly 1,750 clinical trials for the creation of vaccines and medications for the treatment of COVID-19 were ongoing as of January 2021, according to the Pharmaceutical Research and Manufacturers of America, 420 of which were based in the United States.

Recent Developments:

  • Eli Lilly and Company announced in February 2021 that it had entered into a US$ 960 million strategic collaboration and license agreement with Rigel Pharmaceuticals to jointly develop and market R552, an inhibitor of the receptor-interacting serine/threonine protein kinase 1 (RIPK1) According to the terms of the contract, Rigel will receive a US$125 million upfront payment from Eli Lilly, as well as an additional US$835 million in potential development, regulatory, as well as commercial milestone payments.
  • Amgen Inc. announced a strategic alliance with McKesson in December 2020. The agreement will contribute to the advancement of cancer treatment in settings that provide community cancer care. By providing Amgen medication, McKesson reaches 20% of cancer patients in the US. With the aim of closing care gaps by enhancing access to cutting-edge personalized medicine and immuno-oncology in the community setting, this multiyear agreement brings together the strength and reach of the two businesses.
  • Roche and the Global Fund announced a partnership in May 2022 to help low- and middle-income nations build up their vital diagnostic infrastructure in the fight against AIDS, TB, and malaria. As part of this partnership, a strong procedure will be established for gathering, transporting, testing, and providing results to patients in time for clinical intervention. New strategies to lessen the financial and environmental burden of healthcare waste generated during the testing process will also be a part of the partnership.
  • Arena Pharmaceuticals, a company focused on creating cutting-edge potential therapies for the treatment of a variety of immuno-inflammatory diseases, was acquired by Pfizer, Inc. in March 2022. In addition to etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently being developed for several immuno-inflammatory diseases like ulcerative colitis, Crohn’s disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata, Arena Pharmaceuticals also provides to Pfizer a portfolio of other promising development-stage therapeutic candidates in gastroenterology, dermatology.
  • Johnson & Johnson launched the health equity innovation challenge in September 2021 with the intention of helping to address racial healthcare disparities at the local level in Chicago, Detroit, Los Angeles, New Orleans, New York City, and Philadelphia. To find and expedite innovations with the potential to reduce those historical disparities, the company has launched the Johnson & Johnson Health Equity Innovation Challenge.

One of the most important goals of biopharmaceutical innovation is to contribute to lower mortality and premature death rates. The Manhattan Institute recently published a research study on the reasons why the average life expectancy and longevity vary from country to country. The effective contribution of new bio drugs demonstrates that the more we use new bio drugs, the more we gain longevity and provide welfare to the population. Furthermore, tailoring drug formulations to specific patients and cases leads to improved cures and reduce premature mortality, both of which are important public health goals. Since the biopharmaceutical field was further revolutionized and initiated—to develop and discover new bio drugs—we have observed that this contributes to an increase in average life expectancy6, indicating a significant impact.

Bio-pharma firms can create drugs from biological components of substances known as biologics, which include sugars, proteins, nucleic acids such as DNA and RNA, and complex combinations of components. Biologics, or their precursors or components, are isolated from living sources such as humans, animals, plants, fungi, or microbes. Because they are structurally identical, these drugs are frequently more effective and have fewer side effects.

The majority of biopharmaceuticals are derived from naturally occurring proteins. Biopharmaceuticals are also derived from recombinant proteins, which are special proteins that contain genes that scientists have manipulated. The changes cause the proteins to behave in a specific manner; because the changes are encoded in the genes, each subsequent generation of proteins carrying the modified genes will behave in the same manner.

You can place an order or ask any questions, please feel free to contact us at [email protected]

Advertisement

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Browse our Brand-New Journal@ https://www.towardspackaging.com

Browse our Consulting Website@ https://www.precedenceresearch.com

For Latest Update Follow Us:

Advertisement

https://www.linkedin.com/company/towards-healthcare

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

ADQ Appoints Modon as Master Developer for Ras El Hekma Megaproject in Egypt

Published

on

adq-appoints-modon-as-master-developer-for-ras-el-hekma-megaproject-in-egypt

In the presence of Mohamed bin Zayed Al Nahyan and Abdel Fattah El-Sisi
The event marked the signing of several significant agreements aimed at driving the development of the new destinationABU DHABI, UAE, Oct. 4, 2024 /PRNewswire/ — In the presence of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, and His Excellency Abdel Fattah El-Sisi, President of the Arab Republic of Egypt, ADQ, an Abu Dhabi-based investment and holding company, appointed Modon Holding PSC as the master developer for the Ras El Hekma megaproject.

In addition to being master developer for the entire development spanning 170 million square metres, Modon Holding will undertake the responsibility of the developer role for the first phase of the envisaged city consisting of 50 million square metres.
The remaining 120 million square metres, which are part of the master plan presented by Modon Holding, will be developed in partnership with prominent developers from Egypt, the UAE, and the international community under the oversight of the recently established ADQ subsidiary Ras El Hekma Urban Development Project Company and Modon Holding.
This iconic project represents a major milestone for Modon Holding by significantly increasing its land under development outside the UAE. Ras El Hekma is located around 350 kilometres northwest of Cairo and envisioned as a fully functional, smart, sustainable, and inclusive urban community situated against the scenic coastline.
The project is expected to become a powerful economic engine, with cumulative investments anticipated to reach US$110 billion by 2045, an annual GDP contribution of around US$25 billion, and approximately 750,000 jobs to be created, both directly and indirectly.
Upon completion, the development will be home to two million people and feature more than 40 kilometres of green spines, set to make Ras El Hekma the greenest megaproject in the region.
As a result of Ras El Hekma’s location within a four-hour flight for over 400 million outbound tourists, the establishment of tourism infrastructure will be a priority during the first phases of the development, encompassing an international airport as well as high-speed rail connectivity. The masterplan also includes residential areas, office spaces, hospitality venues, retail, leisure, and recreation facilities.
Ras El Hekma will have an international marina and a special free zone. Additionally, Modon Holding will look to develop infrastructure to support a range of high-growth industries, including business services, financial services, light manufacturing, and technology.
His Excellency Jassem Mohamed Bu Ataba Al Zaabi, Chairman of Modon Holding, said, “Ras El Hekma is destined to become a regional crown jewel in a country already famed for its rich and diverse attractions. Modon Holding is proud to bring this 170-million-square-metre visionary megaproject to life, leveraging our expertise and innovative approach. With our partners, we are poised to transform Ras El Hekma into a dynamic economic powerhouse and a global model for urban development.”
His Excellency Mohamed Hassan Alsuwaidi, Managing Director and Group Chief Executive Officer of ADQ, said, “As a project of unprecedented scale and impact, Ras El Hekma will be a catalyst for the development of Egypt’s economy by offering opportunities for businesses and stimulate tourism. Modon Holding brings a wealth of expertise in master planning and will pioneer state-of-the-art, innovative solutions, creating a destination that will deliver long-term value for Egypt and its people.”
Bill O’Regan, Group CEO of Modon Holding, said, “The Ras El Hekma destination is one of the Group’s most significant investment and development projects outside the UAE. The project provides an incredible development pipeline, and Modon Holding looks forward to delivering a destination that will be an exceptional experience for visitors and residents alike.”
During the ceremony, Modon Holding PSC engaged with the initial major partners to join in the development of the Ras El Hekma megaproject on Egypt’s stunning Mediterranean coast.
Ras El Hekma is set to become a leading urban and tourist hub, boasting a wide array of attractions and amenities. Modon Holding aims to harness its large-scale development expertise, collaborating with local, regional, and global partners to bring this visionary destination masterplan to life.
These collaborative efforts, combined with a focus on diverse entertainment, sports, cultural events, and top-tier community management, will position Ras El Hekma as a premier Mediterranean destination.
While the immediate focus is on tourism and hospitality, Modon’s long-term vision for the 170-square-metre site also includes business services, financial services, light manufacturing, and technology.
Modon Engages First Batch of Investors and Partners in Landmark Ceremony
On 4th October, in a momentous ceremony attended by President His Highness Sheikh Mohamed bin Zayed Al Nahyan and Egyptian President His Excellency Abdel Fattah El-Sisi, Modon proudly initiated the engagement of its first group of investors and partners.
The event marked the signing of several significant agreements aimed at driving the development of the new destination:
– A framework agreement with Orascom Construction, designating them as one of the primary contractors for the initial phase of the project.
– A memorandum of understanding with Elsewedy Electric to explore opportunities for supplying building materials and collaborating on industrial parks, manufacturing, operations, and maintenance.
– A memorandum of understanding with Abu Dhabi Airports to collaborate in airport strategic planning, design, development, and operational support.
– A memorandum of understanding with TAQA to explore cooperation opportunities in relation to the development, financing, and operation of greenfield utilities infrastructure projects, water desalination projects, electricity transmission and distribution projects and wastewater projects.
– A memorandum of understanding with Valderrama for the development and operation of golf communities.
– A memorandum of understanding with e& Egypt to facilitate the design and implementation of smart city infrastructure, including digital connectivity, fiber networks, and 5G; smart building technologies and IoT-enabled solutions for residential and commercial properties; city-wide data collection, monitoring, and analytics systems; smart utilities, encompassing automated energy management, water, and waste systems; smart transportation systems; and any other mutually agreed smart city services.
– A memorandum of understanding with Candy International aims to explore luxury real estate development opportunities, leveraging Candy’s extensive international reach.
– A memorandum of understanding with Montage International for the development and management of luxury hotels in Ras El Hekma.
– A memorandum of understanding with Accor and Ennismore to operate hotels and resorts in Ras El Hekma.
– Finally, a memorandum of understanding with Burjeel Holding to develop multi-specialty healthcare facilities, implement innovative healthcare solutions, provide medical training programmes, and collaborate on public health initiatives and community wellness programmes.
These strategic partnerships underscore Modon’s commitment to creating a world-class destination, fostering innovation, and enhancing the quality of life for Ras El Hekma’s future residents.
His Excellency Jassem Mohamed Bu Ataba Al Zaabi, said, “Ras El Hekma represents a visionary and multifaceted endeavour that promises to make a substantial contribution to the Egyptian economy. Crafting a masterplan of such scale demands specialised expertise and capabilities across diverse industries, which can only be realised through robust strategic partnerships. We look forward to working with our partners present and future in harnessing the full potential of this extraordinary location.”
Bill O’Regan, said, “Ras El Hekma is an extraordinarily ambitious and complex project that will significantly contribute to the Egyptian economy through various stages of planning, design, and construction, ultimately bringing this new destination to life. Developing and delivering a masterplan of this magnitude requires sector-specific expertise and capabilities across a wide range of industries and is achievable only through strong strategic partnerships.”
About ADQEstablished in 2018, ADQ is an Abu Dhabi-based investment and holding company with a broad portfolio of major enterprises. Its investments span key sectors of the UAE’s diversified economy including energy and utilities, food and agriculture, healthcare and life sciences, and transport and logistics, amongst others. As a strategic partner to the Government of Abu Dhabi, ADQ is committed to accelerating the transformation of the Emirate into a globally competitive and knowledge-based economy. 
For more information, visit adq.ae or write to [email protected]. You can also follow ADQ on Instagram, LinkedIn and X.
About Modon HoldingModon develops vibrant communities, unique hospitality and lifestyle experiences, and world-class sports facilities. Based in Abu Dhabi, Modon Holding is a Private Joint Stock company listed on the ADX Growth Market with the shareholding of ADQ and the IHC Group being our majority shareholders. Through a diversified business portfolio in the UAE, we are engaged in strategic investment and innovation on an unrivalled scale, shaping future smart living. Our goal is to deliver long-term, sustainable value, laying the foundations for intelligent, connected living.
Ras El-Hekma Urban Development Project CompanyA wholly owned subsidiary of ADQ, an Abu Dhabi-based investment and holding company, Ras El Hikma Urban Development Project Company S.A.E. (RED) is mandated to oversee the execution of the Ras El Hekma project, a 170 million square meter visionary megacity located on Egypt’s north coast. Established in March 2024 and based in Egypt, RED holds the ownership rights of the Ras El-Hekma as well as responsibility for the implementation of the multi-phase project together with its partners, which include Modon Holding as the master developer.
Photo – https://mma.prnewswire.com/media/2523688/Modon_ADQ.jpg

View original content:https://www.prnewswire.co.uk/news-releases/adq-appoints-modon-as-master-developer-for-ras-el-hekma-megaproject-in-egypt-302267927.html

Continue Reading

Artificial Intelligence

Electronic Access Control Systems Market Set for Significant Expansion, with Projected Growth to USD 16 Billion by 2031: Market Research Intellect

Published

on

electronic-access-control-systems-market-set-for-significant-expansion,-with-projected-growth-to-usd-16-billion-by-2031:-market-research-intellect

The Electronic Access Control System market is driven by increasing security concerns and advancements in technology. As businesses and institutions face growing threats, there is a rising demand for sophisticated access control solutions to protect assets and data. Technological innovations, including biometrics, IoT integration, and cloud-based systems, enhance system functionality and appeal. Additionally, the trend toward smart buildings and stringent regulatory requirements further fuels the market’s expansion, reflecting a broadening need for advanced security solutions.
LEWES, Del., Oct. 4, 2024 /PRNewswire/ — The Electronic Access Control System market is projected to grow from approximately USD 10 billion in 2024 to USD 16 billion by 2031, achieving a compound annual growth rate (CAGR) of around 7.5%. This growth is driven by rising security needs, advancements in technology, and increased adoption of smart and connected security solutions across various sectors.

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=194769
202 – Pages126 – Tables37 – Figures
Scope Of The Report
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2031
BASE YEAR
2023
FORECAST PERIOD
2024-2031
HISTORICAL PERIOD
2020-2023
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Honeywell International Inc., Johnson Controls International plc, ASSA ABLOY Group, Allegion plc, Schlage (a brand of Allegion), Bosch Security Systems, Tyco International Ltd., and HID Global (an ASSA ABLOY Group brand).
SEGMENTS COVERED
By Type, By Application And By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope
Electronic Access Control System Market Overview
Market Size and Growth:The Electronic Access Control System market is experiencing robust growth, expected to expand from approximately USD 10 billion in 2024 to USD 16 billion by 2031, representing a compound annual growth rate (CAGR) of about 7.5%. This growth trajectory is driven by the increasing need for enhanced security solutions across various sectors, including commercial, residential, and industrial applications. The rising concerns over security breaches and unauthorized access are prompting organizations to invest in advanced access control technologies. Additionally, the growing adoption of smart buildings and connected infrastructure contributes to the market’s expansion, as these technologies offer more efficient and scalable security solutions. As the demand for higher security standards continues to rise, the EACS market is poised for substantial growth in the coming years.Technological Advancements:The EACS market is significantly influenced by rapid technological advancements. Innovations such as biometric authentication, including fingerprint and facial recognition, are enhancing the capabilities of access control systems, providing more secure and user-friendly solutions. The integration of Internet of Things (IoT) technology allows for remote monitoring and management of access control systems, increasing their flexibility and effectiveness. Cloud-based solutions are also gaining traction, offering scalable and cost-effective options for businesses of all sizes. These technological advancements not only improve security but also streamline system management and integration with other smart technologies. As the technology continues to evolve, the EACS market is expected to benefit from more sophisticated, efficient, and adaptable access control solutions that meet the growing demands for security and convenience.Market Drivers:The primary drivers of the EACS market include heightened security concerns and the need for compliance with regulatory standards. Organizations across various sectors are increasingly investing in advanced access control solutions to safeguard their assets, sensitive information, and personnel. The growing frequency of security breaches and unauthorized access incidents further amplifies the need for reliable and robust security systems. Additionally, the trend toward smart buildings and the integration of IoT technology are driving market growth by offering more sophisticated and interconnected security solutions. Regulatory requirements related to data protection and physical security are also influencing the adoption of EACS, as businesses seek to meet these standards while ensuring the safety and security of their operations.Regional Insights:The EACS market shows varying growth patterns across different regions. North America and Europe lead the market due to their high adoption rates of advanced security technologies and stringent regulatory requirements. In these regions, the emphasis on high-security standards and the presence of major market players contribute to significant market growth. Conversely, the Asia-Pacific region is emerging as a key growth area due to rapid urbanization, industrialization, and increasing investments in infrastructure development. Countries such as China and India are witnessing a surge in demand for electronic access control systems as they modernize their infrastructure and enhance security measures. The diverse regional dynamics reflect varying levels of market maturity and growth opportunities, influencing the overall global market landscape.Download Sample Report Now: https://www.marketresearchintellect.com/download-sample/?rid=194769Market Segmentation:The EACS market can be segmented based on type, application, and technology. Key types include biometric systems, card-based systems, and electronic locks. Biometric systems are gaining popularity for their high security and convenience, while card-based systems remain widely used due to their affordability and ease of integration. Electronic locks offer versatile security options for both residential and commercial applications. In terms of application, the market serves commercial buildings, residential complexes, government facilities, and industrial sites. Each segment has unique requirements and preferences, driving the development of specialized solutions. Technology-wise, advancements such as IoT integration, cloud-based systems, and mobile access are shaping the market, offering improved functionality and user experience. Understanding these segments helps stakeholders tailor their offerings to meet diverse market needs effectively.Challenges:Despite its growth, the EACS market faces several challenges. High initial investment costs can deter small and medium-sized enterprises (SMEs) from adopting advanced access control solutions. Integration complexities, particularly with existing security infrastructure, can also pose hurdles for implementation. Additionally, concerns about data privacy and cybersecurity risks associated with connected systems may affect market adoption. The rapid pace of technological advancements requires continuous updates and upgrades, adding to the cost and complexity of maintaining access control systems. Addressing these challenges involves developing cost-effective solutions, enhancing system compatibility, and ensuring robust cybersecurity measures. Overcoming these obstacles is crucial for market players to successfully expand their customer base and capture emerging opportunities in the evolving security landscape.Competitive Landscape:The EACS market is characterized by intense competition, with numerous players vying for market share. Major companies include Honeywell, Johnson Controls, ASSA ABLOY, and Allegion, each offering a range of innovative products and solutions. These players focus on technological advancements, strategic partnerships, and mergers and acquisitions to strengthen their market positions. Additionally, emerging players and startups are introducing novel solutions, contributing to market dynamism and innovation. Competitive strategies involve differentiating products through advanced features, improving customer service, and expanding distribution channels. As the market evolves, companies must stay ahead of technological trends and customer demands to maintain a competitive edge and drive growth in a rapidly changing environment.Future Outlook:The future outlook for the EACS market is promising, with continued growth expected as security concerns and technological advancements drive demand. Emerging trends such as the integration of artificial intelligence (AI) and machine learning are likely to enhance system capabilities, providing more proactive and intelligent security solutions. The growing emphasis on smart cities and connected infrastructure will further propel market growth, as EACS plays a crucial role in modernizing urban environments. Additionally, increasing awareness of data privacy and security will lead to greater adoption of advanced access control systems. As the market evolves, stakeholders should focus on innovation, user experience, and addressing emerging security challenges to capitalize on future opportunities and sustain long-term growth.Geographic Dominance:
The Electronic Access Control System market exhibits significant geographic dominance, with North America and Europe leading due to their advanced infrastructure and stringent regulatory standards. North America, particularly the United States, holds a substantial share of the market, driven by high security concerns, technological advancements, and a robust presence of major EACS providers. Europe follows closely, with countries like the UK, Germany, and France investing heavily in security solutions due to strict regulations and high adoption rates. Meanwhile, the Asia-Pacific region is emerging as a major growth area, fueled by rapid urbanization, industrial expansion, and increasing investments in smart infrastructure. Countries such as China and India are witnessing rising demand for advanced access control systems as they modernize and enhance their security measures. The diverse regional dynamics highlight varying levels of market maturity and growth potential across the globe.
Electronic Access Control System Market Key Players Shaping the Future
The Electronic Access Control System market is significantly influenced by key players such as Honeywell International Inc., Johnson Controls International plc, ASSA ABLOY Group, Allegion plc, Schlage (a brand of Allegion), Bosch Security Systems, Tyco International Ltd., and HID Global (an ASSA ABLOY Group brand). These companies are at the forefront of technological innovation and market development, shaping the future of access control solutions through their advanced products and strategic initiatives.
Electronic Access Control System Market Segment Analysis
The Electronic Access Control System market is segmented based on By Type, By Application and Geography, offering a comprehensive analysis of the industry.
By Type:
Biometric Systems: These systems use unique biological characteristics, such as fingerprints, facial recognition, and iris scans, to provide secure access. They offer high security and are increasingly adopted in sensitive areas.Card-Based Systems: These systems use magnetic stripe cards, smart cards, or proximity cards to control access. They are popular due to their affordability, ease of use, and integration capabilities.Electronic Locks: These include keypads, smart locks, and other electronic mechanisms that can be controlled remotely or via electronic credentials. They are versatile and used in various residential and commercial settings.By Application:
Commercial Buildings: EACS in commercial buildings includes office complexes, retail spaces, and hospitality venues. These systems focus on managing employee access, visitor control, and security integration.Residential Complexes: Access control systems for residential complexes include apartment buildings and gated communities, emphasizing security and convenience for residents.Government Facilities: High-security access control solutions are used in government buildings, military bases, and other critical infrastructure to ensure tight security and regulatory compliance.Industrial Sites: EACS for industrial sites manage access to sensitive areas, protect valuable assets, and ensure safety compliance in manufacturing and industrial environments.By Geography:
North America: This region leads the market due to high adoption rates of advanced security technologies, stringent regulations, and a strong presence of major market players.Europe: Europe follows closely, with significant market activity in countries such as the UK, Germany, and France, driven by regulatory standards and high security needs.Asia-Pacific: The Asia-Pacific region is emerging as a key growth area, with increasing urbanization, industrial expansion, and investments in smart infrastructure driving demand for EACS.Latin America: Growth in Latin America is fueled by increasing security concerns and infrastructural development, with a growing adoption of electronic access solutions.Middle East and Africa: The market in this region is expanding due to rising security needs and infrastructure projects, with increasing investments in advanced access control technologies. Automotive And Transportation:
The Electronic Access Control System  market within the automotive and transportation sector is experiencing notable growth, driven by advancements in vehicle security and the need for enhanced access management. In vehicles, EACS technology includes electronic locks, biometric systems, and keyless entry solutions that improve convenience and security for drivers and passengers. These systems are increasingly integrated into both commercial and personal vehicles, offering features such as remote access control, advanced theft prevention, and personalized settings. In the transportation sector, EACS is utilized for secure access to restricted areas within transportation hubs, including airports, train stations, and cargo facilities. This enhances the management of personnel and vehicle access, contributing to overall safety and operational efficiency. As the demand for smarter and more secure transportation solutions grows, the EACS market is expected to expand, driven by ongoing innovations and the increasing adoption of connected technologies.
Our related Reports
Global Automotive Pneumatic Valve Market is categorized based on Type (Engine Valves, Brake Valve, Thermostat Valve, Fuel System Valve, Solenoid Valve, Exhaust Gas Recirculation Valve, Tire Valve, Water Valve, AT Control Valve, Others) and Application (Engine System, HVAC System, Brake System, Others) and geographical regions
Global Automotive Pneumatic Comfort Seat System Market is categorized based on Type (Pneumatic Lumbar Support Systems, Pneumatic Seat Cushion Systems, Pneumatic Seat Back Systems, Massage Systems, Adjustable Seat Systems) and Application (Passenger Vehicles, Commercial Vehicles, Luxury Vehicles, Sports Vehicles, Public Transportation) and geographical regions
Global Automotive Pneumatic Disc Brake Market is categorized based on Type (Cast Iron, Others) and Application (Passenger Vehicle, Commercial Vehicle) and geographical regions
Global Automotive Pneumatic Disc Brake Market is categorized based on Type (Single-piston Pneumatic Disc Brakes, Multi-piston Pneumatic Disc Brakes, Caliper Pneumatic Disc Brakes, Rotor Pneumatic Disc Brakes, Drum-in-hat Pneumatic Disc Brakes) and Application (Passenger Cars, Commercial Vehicles, Racing Cars, Heavy-duty Trucks, Off-road Vehicles) and geographical regions
Global Antibacterial Nano Coatings Market is categorized based on Application (Silver Nanoparticle Coatings, Copper Nanoparticle Coatings, Zinc Oxide Nanoparticle Coatings) and Product (Medical Devices (Implants, Catheters), Food Packaging, Textiles, Healthcare Surfaces) and geographical regions
Global Antibacterial in Agriculture Market is categorized based on Type (Amide Antibacterials, Antibiotic Antibacterials, Copper-Based Antibacterials, Dithiocarbamate Antibacterials, Other Types) and Application (Foliar Spray, Soil Treatment, Other Modes of Application) and geographical regions
About Us: Market Research Intellect
Welcome to Market Research Intellect, where we lead the way in global research and consulting, proudly serving over 5,000 esteemed clients worldwide. Our mission is to empower your business with cutting-edge analytical research solutions, delivering comprehensive, information-rich studies that are pivotal for strategic growth and critical revenue decisions.
Unmatched Expertise: Our formidable team of 250 highly skilled analysts and subject matter experts (SMEs) is the backbone of our operations. With extensive training in advanced data collection and governance, we delve into over 25,000 high-impact and niche markets. Our experts seamlessly integrate modern data collection techniques, robust research methodologies, and collective industry experience o produce precise, insightful, and actionable research.
Diverse Industry Coverage: We cater to a wide array of industries, ensuring that our insights are both relevant and specialized. Our expertise spans: Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages
Having collaborated with numerous Fortune 2000 companies, we bring unparalleled experience and reliability to meet all your research needs. Our proven track record reflects our commitment to excellence and client satisfaction.
Contact Us:Mr. Edwyne FernandesMarket Research IntellectCall Us on: +1 743 222 5439Email: [email protected]: https://www.marketresearchintellect.com/LinkedIn: https://www.linkedin.com/company/marketresearchintellectTwitter: https://x.com/intellectmr
Logo: https://mma.prnewswire.com/media/2483702/Market_Research_Intellect_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/electronic-access-control-systems-market-set-for-significant-expansion-with-projected-growth-to-usd-16-billion-by-2031-market-research-intellect-302267707.html

Continue Reading

Artificial Intelligence

System-on-Chip (SoC) Market worth $205.97 billion by 2029 – Exclusive Report by MarketsandMarkets™

Published

on

system-on-chip-(soc)-market-worth-$205.97-billion-by-2029-–-exclusive-report-by-marketsandmarkets™

DELRAY BEACH, Fla., Oct. 4, 2024 /PRNewswire/ — The System-on-Chip (SoC) market is projected to grow from USD 138.46 billion in 2024 and is estimated to reach USD 205.97 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 8.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of the System-on-Chip (SoC) market is driven with the increasing trend of SoC in automotive industry along with the adoption of IoT and connected devices that require SoCs to carry out real time processing. Moreover, the surging adoption of AI and machine learning technologies is likely to fuel the demand for system-on-chips.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=99622125
Browse in-depth TOC on “System-on-Chip (SoC) Market” 
250 – Tables73 – Figures326 – Pages
System-on-Chip (SoC) Market Report Scope:
Report Coverage
Details
Market Revenue in 2024
$ 138.46 billion
Estimated Value by 2029
$ 205.97 billion
Growth Rate
Poised to grow at a CAGR of 8.3%
Market Size Available for
2020–2029
Forecast Period
2024–2029
Forecast Units
Value (USD Million/Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
By Core Count, Core Architecture, Device and Region
Geographies Covered
North America, Europe, Asia Pacific, and Rest of World
Key Market Challenge
Rapid technological changes challenge SoC longevity
Key Market Opportunities
Growing penetration of AI PCs and GenAI smartphones
Key Market Drivers
Rising adoption of ADAS in autonomous vehicles to fuel the growth of automotive SoCs
By core architecture, RISC-V is projected to grow at a high CAGR for system-on-chip market during the forecast period
The market for System-on-Chips (SoC) for RISC-V architecture segment is expected to grow at highest CAGR during the forecast period. The RISC-V architecture is bound to grow at a higher rate in view of the flexibility, cost, and scalability advantages it has over others, driving wide adoption across diversified applications. The open-source nature of the architecture is one of the major growth drivers because it reduces licensing costs and accelerates innovation since customizations are allowed for use cases as per various needs. This flexibility is valuable in the emerging and high-growth sectors of AI, 5G, and IoT, where a solution that is tailor-made to complex requirements needs to be provided. For instance, in May 2024, Arteris, Inc. (US) and Andes Technology Corporation (Taiwan) partnered to develop the Andes Qilai RISC-V platform. It incorporates the high-performance RISC-V processor IPs from Andes Technology Corporation (Taiwan) and the FlexNoC interconnect IP from Arteris, Inc. (US). Their joint effort shows their efforts towards advancing RISC-V based SoC designs for a wide range of applications, which include AI, 5G, Networking, Mobile, Storage, AIoT, and Space. With open-source RISC-V model, such developments further continue to accelerate innovation and drive adoption in these high-growth areas, positioning RISC-V as the choice for future technology roadmaps.
The automotive segment in System-on-Chip (SoC) market will account for the high CAGR from 2024 to 2029
The SoC market for automotive segment will grow at highest CAGR during the forecast period. The SoCs integrated in automotive applications enable enhanced performance, reduced power consumption, and compact designs, which makes them essential for numerous vehicle systems. The automotive segment will experience growth due to the increasing adoption of advanced driver assistance systems (ADAS), infotainment systems, and the rising popularity of electric vehicles. EVs rely heavily on sophisticated electronics for battery management, powertrain control, and energy efficiency optimization, all of which require advanced SoCs. For instance, in June 2024, Intel Corporation (US) launched OLEA U310 SoC chip for automotive applications. It is developed to improve the performance of electric vehicles. This chip combines hardware and software in one SoC to enable seamless operation across various EV station platforms. They are designed to manage the complex systems within EVs. It ensures optimal performance, safety, and extended range. The increasing complexity of autonomous driving systems, along with the demand for safer and more reliable vehicles fuels the adoption of SoCs in the automotive industry, driving significant growth in this segment.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=99622125
Asia Pacific is expected to register the highest CAGR during the forecast period
The system-on-chip (SoC) industry in Asia Pacific includes economies such as South Korea, Japan, China, and India and Rest of Asia Pacific. The Rest of Asia Pacific countries include Australia, Singapore, the Philippines, Taiwan, Thailand, and Indonesia. There is a presence of leading SoC manufacturers in this region including MediaTek Inc. (Taiwan), Samsung (South Korea), Infineon Technologies AG (Germany), and Renesas Electronics Corporation (Japan). The Asia-Pacific region is still the biggest revenue generator in terms of SoC market globally due to the fast-growing consumer electronics and mobile device-related sectors. Other regions considered as major manufacturing centers in the world are China, South Korea, Japan, and India for making the latest smartphones, tablets, and other consumer electronic products that require state-of-the-art SoCs for delivering high performance, energy efficiency, and integrated functionalities. A highly and technologically advanced population in the region has always formed the basis for a sustained demand in terms of innovative and feature-rich devices, thereby showing sustainable growth in the SoC market. Automotive and industrial automation are another major sector driving the SoC market in Asia Pacific. This region contains some of the largest automobile manufacturers in the world, such as Hyundai Motor Company (South Korea), Toyota (Japan), and Tata Motors Limited (India). These car manufacturers are now putting SoCs into their automobiles so that they are equipped with ADAS capabilities, infotainment features, and autonomous driving technologies.
Key Players
Key companies operating in the System-on-Chip (SoC) companies are Qualcomm Technologies, Inc. (US), MediaTek Inc. (Taiwan), Samsung (South Korea), Apple Inc. (US), Broadcom (US), Intel Corporation (US), Advanced Micro Devices, Inc. (US), NVIDIA Corporation (US), HiSilicon (China), Microchip Technology Inc. (US), among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=99622125
Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting
Related Reports: 
Field Programmable Gate Array (FPGA) Market Size, Share & Industry Trends Analysis Report by Configuration (Low-end FPGA, Mid-range FPGA, High-end FPGA), Technology (SRAM, Flash, Antifuse), Node Size (=16 nm, 20-90 nm, >90 nm), Vertical (Telecommunications, Data Center & Computing, Automotive) & Region – Global Forecast to 2029
Chiplet Market Size, Share, Statistics and Industry Growth Analysis Report by Processor (Field-Programmable Gate Array (FPGA), Central Processing Unit (CPU), Graphics Processing Unit (GPU), APU, AI ASIC Co-Processor), Packaging Technology (SiP, FCCSP, FCBGA, 2.5D/3D, WLCSP, Fan-Out) – Global Forecast to 2028
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected] Our Web Site: https://www.marketsandmarkets.com/Research Insight: https://www.marketsandmarkets.com/ResearchInsight/sos-companies.aspContent Source: https://www.marketsandmarkets.com/PressReleases/sos.asp
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

View original content:https://www.prnewswire.co.uk/news-releases/system-on-chip-soc-market-worth-205-97-billion-by-2029—exclusive-report-by-marketsandmarkets-302267585.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending